Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Signs MOU to Mine High Grade Zone 2 at Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PharmAthene PIP

Healthcare Biotechnology
"PharmAthene Inc is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States."

Recent & Breaking News (NYSEAM:PIP)

PharmAthene Reports First Quarter 2017 Financial and Operational Results

PR Newswire May 3, 2017

PharmAthene Reports Year-End 2016 Financial and Operational Results

PR Newswire March 14, 2017

PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction with Altimmune

PR Newswire March 13, 2017

Altimmune to Present at the BIO CEO & Investor Conference

PR Newswire February 6, 2017

Research Reports Coverage on Biotech Stocks -- PharmAthene, Corcept Therapeutics, Navidea Biopharma, and Inotek Pharma

PR Newswire January 25, 2017

Mid-Afternoon Market Update: Dow Slides Over 100 Points; CSX Shares Spike Higher

Benzinga.com  January 19, 2017

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

PR Newswire January 19, 2017

PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

PR Newswire November 17, 2016

PharmAthene Receives Final Payment from SIGA of $83.9 Million

PR Newswire November 16, 2016

PharmAthene Reports Third Quarter 2016 Financial and Operational Results

PR Newswire November 4, 2016

PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process

PR Newswire August 25, 2016

BLACKROCK WORLD MINING TRUST PLC - Net Asset Value(s)

PR Newswire UK Disclosure August 5, 2016

PIPEHAWK PLC - QM Systems contract extension with Hadley Industries

PR Newswire UK Disclosure August 5, 2016

BLACKROCK INVESTMENT TRUSTS - Net Asset Value(s)

PR Newswire UK Disclosure August 5, 2016

PIPEHAWK PLC - QM Systems partnership with UK-NSI Co., Ltd

PR Newswire UK Disclosure August 4, 2016

PharmAthene to Join Russell 3000® and Global Indexes

PR Newswire June 23, 2016

PIPEHAWK PLC - QM Systems contract win with Primafruit Ltd

PR Newswire UK Disclosure May 19, 2016

PIPEHAWK PLC - QM Systems contract win with Mann & Hummel

PR Newswire UK Disclosure May 11, 2016

PharmAthene Reports First Quarter 2016 Financial and Operational Results

PR Newswire May 9, 2016

PharmAthene Reports Court Approval of SIGA Reorganization Plan to Exit from Bankruptcy

PR Newswire April 13, 2016
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested